General Western Blot Reagents
Abcam Human PSMA peptide, 1MG
Human PSMA peptide is a Synthetic blocking peptide. >70% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: FOLH, NAALAD1, PSM, PSMA, GIG27, FOLH1, Glutamate carboxypeptidase 2, Cell growth-inhibiting gene 27 protein, Folate hydrolase 1, Folylpoly-gamma-glutamate carboxypeptidase, Glutamate carboxypeptidase II, Membrane glutamate carboxypeptidase, N-acetylated-alpha-linked acidic dipeptidase I, Prostate-specific membrane antigen, Pteroylpoly-gamma-glutamate carboxypeptidase, FGCP, GCPII, mGCP, NAALADase I
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human proBNP peptide, 100UG
Human proBNP peptide is a Synthetic blocking peptide. >95% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: Natriuretic peptides B, Brain natriuretic factor prohormone, Gamma-brain natriuretic peptide, Iso-ANP, preproBNP, proBNP, NPPB
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam MU-GLU, Fluorogenic beta-glucosidase substrate, 100MG
MW 338.32 g/mol. Fluorogenic substrate of β-glucosidase and β-glucocerebrosidase (also known as glucosylceramidase). Used for characterizing novel β-glucosidases. Also used in assays to evaluate deficiency in β-glucocerebrosidase activity related to Gaucher disease. Hydrolysis releases the fluorescent product 4-MU. Fluorescence: λex 365 nm; λem 445 nm in 0.1 M sodium acetate pH 5.0 (after cleavage by β-glucosidase).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ro 25-6981 maleate salt (mM/ml), NR2B antagonist, 20MM_ML
MW 455.5 Da, Purity >98%. Potent, highly selective, activity-dependent blocker of NMDA receptors that contain the NR2B subunit (IC₅₀ values are 0.009 and 52 μM at NR1C/NR2B and NR1C/NR2A, respectively). Displays no significant activity at kainate/AMPA receptors, Na+ and Ca²+ channels at concentrations showing maximal protection in neurotoxicity tests. Neuroprotective actions in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mouse Interferon beta protein, 50UG
Mouse Interferon beta protein is a Mouse Full Length protein, in the 30 to 379 aa range, expressed in HEK 293, <= 0.005 EU/µg endotoxin level and suitable for SDS-PAGE, HPLC, MS.
Protein/ Peptide/ Enzyme Synonyms: Ifb, Ifnb, Ifnb1, Interferon beta, IFN-beta
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human MLKL (phospho S358) peptide, 1MG
Human MLKL (phospho S358) peptide is a Synthetic blocking peptide. Suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: Mixed lineage kinase domain-like protein, hMLKL, MLKL
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam MIRA-1, p53 inducer, 10MG
MW 183.16 Da, Purity >99%. Novel, nontoxic and selective p53 inducer. Antitumor agent. Promotes tumor cell apoptosis in a mutant p53-dependent manner (IC₅₀ = 10 μM) and prolongs survival. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (R)-Butaprost, EP2 agonist, 5MG
MW 408.6 Da, Purity >98%. Selective EP2 agonist. PGE2 structural analog. Inhibits chemotaxis (EC50 = 106 nM, maximal effect of PGE2). Increases neutrophil cyclic AMP levels.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Trichostatin A (DMSO solution), histone deacetylase inhibitor, 1MG-LQD
MW 302.37 Da, Purity >99%. Potent, selective histone deacetylase (HDAC) inhibitor (Ki = 3.4 nM). Induces cell proliferation, differentiation and apoptosis in vitro. Anticancer and antifungal agent. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Substance P peptide, 100UG
Human Substance P peptide is a Synthetic blocking peptide. >95% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: NKA, NKNA, TAC2, TAC1, Protachykinin-1, PPT
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam KAT13D / CLOCK peptide, 50UG
KAT13D / CLOCK peptide. >95% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: BHLHE8, KIAA0334, CLOCK, Circadian locomoter output cycles protein kaput, hCLOCK, Class E basic helix-loop-helix protein 8, bHLHe8
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam beta-Elemene, Anticancer agent, 25MG
MW 204.35 Da. Anticancer agent. Induces G₂M cell cycle arrest and apoptosis. Induces caspase-3, -7 and -9 activities. Decreases Bcl-2 expression. Induces mitochondrial release of cytochrome c. Inhibits microtubule polymerization. Downregulates uPA, uPAR, MMP-2, and MMP-9 expression. Shows antiproliferative effects. Shows antitumor effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam PRIMA-1MET, p53 activity, 10MG
MW 199.25 Da, Purity >98%. Methylated derivative of PRIMA-1 (ab141641). Restores wild-type conformation and function to mutant p53, and triggers apoptosis in tumor cells. Acts synergistically with chemotherapeutic agents to inhibit tumor cell proliferation. Inhibits thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Concanamycin C, H+-ATPase inhibitor, 500UG
MW 823.1 Da, Purity >98%. Potent, selective vacuolar-type H+-ATPase inhibitor. Macrolide antibiotic agent. Concanamycin A (ab144227) analog. Shows antiproliferative and potent antifungal effects.
The product is subject to the following: Abcam Restricted Use Statement